VIRAL PROTEINS

Country's first mRNA vaccine candidate by Gennova gets nod for conducting human trials: DBT

The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology.

New smartphone-based Covid-19 test gives results in less than 30 minutes, says study

The research found that the device accurately detected a set of positive samples in 5 mins.

Novel coronavirus may enter brain via nose, study says

The research, published in the journal Nature Neuroscience, noted that SARS-CoV-2 not only affects the respiratory tract but also impacts t...

Covid-19: Decades of work, and half a dose of fortune, drove Oxford vaccine success

While skill and hard work drove development, AstraZeneca said it was a minor mistake that made the team realise how they could significantl...

Protein-based COVID-19 vaccine candidates would be more suitable for India, scientists say

The decision on procuring the right COVID-19 vaccine depends on multiple factors, including safety, price and ease of deployment, the scien...

Scientists develop novel method to preserve vaccines without refrigeration

According to the study, published in the journal Biomaterials Science, the viruses in vaccines, which train our cells to identify and vanqu...

CEPI labs to help improve Covid-19 vaccine evaluation

The initiative, led by the not for profit Coalition of Epidemic Preparedness and Innovation (CEPI), is looking to bring in as many global v...

Gene mutation behind different COVID-19 death rates among Indian states, study finds

An international team, led by researchers at Banaras Hindu University (BHU) in Uttar Pradesh, analysed mutations in the gene responsible fo...

Indian scientists find higher viral load in asymptomatic COVID-19 patients

The researchers, including those from the Centre for DNA Fingerprinting and Diagnostics (CDFD) in Hyderabad, advise testing asymptomatic pr...

Are the kids safe? Children may not be as immune to Covid-19 as we think

Data on children as sources of coronavirus spread are sparse.

UK firm declares positive results from clinical trial of COVID-19 protein treatment

Synairgen said its SNG001 formulation uses a protein called interferon beta, which the body produces when it gets a viral infection, and is...

NCBS scientists identify 33 molecules that could be used to treat virus patients

A group of scientists led by Professor R. Sowdhamini at NCBS has identified the 33 small molecules from a database of over 3,30,000 small m...

New, more infectious strain of coronavirus now dominates global cases: Study

According to the research, published in the journal Cell, a variant of the novel coronavirus, named 'D614G', is more infectious in cell cul...

Scientists identify drugs that may block coronavirus from jumping to uninfected cells

They said sometimes this hijacking interferes with the activity of the host's proteins and other important molecules such as enzymes, which...

Chinese, US scientists identify 2 bacterial secreted proteins effective in inactivating coronavirus

As the development of virus-specific vaccines and antiviral drugs usually take a great deal of time, broad-spectrum antiviral drugs could b...

Coronavirus vaccine from Moderna shows early signs of viral immune response

The study was primarily designed to look at the safety of the shot and showed no major warning signs in a small phase 1 trial, the company ...

Nearly 70 drugs that may be effective against Covid-19 identified: Scientists

Around 332 human proteins were found to interact with the SARS-CoV-2 viral proteins, the researchers, including Advait Subramanian, Srivats...